General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery
Status:
Not yet recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
The general decolonization of the human body surface by industrial antiseptic agents, before
elective surgery is recommended by the World Health Organization (WHO).
A specific randomized-controlled trial specifically among high-risk adult orthopedic patients
for infection has not been performed.
In this single-center, prospective, randomized, and controlled superiority trial, which is
planned over a period of two years, we target on an orthopedic patient population with an
elevated risk for revision surgery and surgical site infections
Phase:
Phase 3
Details
Lead Sponsor:
Balgrist University Hospital
Collaborator:
Industry (Schülke & Mayr AG, Switzerland and Germany)